Gogoro 10-K 30 Mar 22 2021 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 29, 2022	Jun. 30, 2021
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2021
Entity File Number	001-39844
Entity Registrant Name	POEMA GLOBAL HOLDINGS CORP.
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1561530
Entity Address, Address Line One	101 Natoma St., 2F
Entity Address, City or Town	San Francisco
Entity Address State Or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	415
Local Phone Number	432 8880
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
ICFR Auditor Attestation Flag	false
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Public Float			$ 333,960,000
Entity Central Index Key	0001826333
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Amendment Flag	false
Auditor Name	WithumSmith+Brown, PC
Auditor Firm ID	100
Auditor Location	New York, New York
Units, each consisting of one share of Class A ordinary share, 0.0001 par value, and one-half of one warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant
Trading Symbol	PPGHU
Security Exchange Name	NASDAQ
Class A Ordinary shares
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares , $0.0001 par value
Trading Symbol	PPGH
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		34,500,000
Class B Ordinary shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		8,625,000
Redeemable warrants included as part of the units
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share
Trading Symbol	PPGHW
Security Exchange Name	NASDAQ

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Assets:
Cash	$ 138,470	$ 0
Prepaid expenses	468,029	0
Total Current Assets	606,499	0
Deferred offering costs	0	436,792
Other non-current assets	6,411	0
Cash and investments held in Trust Account	345,150,792	0
Total Assets	345,763,702	436,792
Liabilities, Redeemable Ordinary shares, and Shareholders' (Deficit) Equity
Accounts payable and accrued expenses	2,252,642	320,829
Promissory note - related party	0	98,016
Total Current Liabilities	2,252,642	418,845
Deferred underwriting commissions	12,075,000	0
Warrant liabilities	41,400,460	0
Total Liabilities	55,728,102	418,845
Commitments and Contingencies
Shareholders' (Deficit) Equity:
Preferred shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding	0	0
Additional paid-in capital	0	24,137
Accumulated deficit	(54,965,263)	(7,053)
Total Shareholders' (Deficit) Equity	(54,964,400)	17,947
Total Liabilities, Redeemable Ordinary Shares and Shareholders' (Deficit) Equity	345,763,702	436,792
Class A Ordinary shares
Shareholders' (Deficit) Equity:
Common stock Value	0	0
Class A Ordinary shares Subject to Redemption
Liabilities, Redeemable Ordinary shares, and Shareholders' (Deficit) Equity
Class A ordinary shares subject to possible redemption, $0.0001 par value, 34,500,000 and 0 shares subject to possible redemption, at redemption value of $10.00 at December 31, 2021 and 2020, respectively	345,000,000	0
Class B Ordinary shares
Shareholders' (Deficit) Equity:
Common stock Value	$ 863	$ 863

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Founder Shares
Common shares, shares outstanding	8,625,000
Class A Ordinary shares
Common shares, par value, (per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	500,000,000	500,000,000
Common shares, shares issued	0	0
Common shares, shares outstanding	0	0
Temporary equity, shares outstanding	34,500,000	0
Class A Ordinary shares Subject to Redemption
Temporary equity, shares outstanding	34,500,000	0
Temporary Equity, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Redemption price per share	10	10
Class B Ordinary shares
Common shares, par value, (per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	50,000,000	50,000,000
Common shares, shares issued	8,625,000	8,625,000
Common shares, shares outstanding	8,625,000	8,625,000

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Operating costs	$ 7,053	$ 3,406,148
Loss from operations	(7,053)	(3,406,148)
Other income (expense):
Interest income on operating account	0	150
Interest earned on cash and investments held in Trust Account	0	150,792
Offering costs allocated to warrant liabilities	0	(1,534,661)
Loss on private placement warrants	0	(5,564,571)
Change in fair value of warrant liabilities	0	650,061
Total other expense	0	(6,298,229)
Net loss	(7,053)	(9,704,377)
Class B Ordinary shares
Other income (expense):
Net loss	$ (7,053)	$ (1,971,014)
Weighted Average Number of Shares Outstanding, Basic	7,500,000	8,600,343
Weighted Average Number of Shares Outstanding, Diluted	7,500,000	8,600,343
Basic net (loss) income per share	$ 0	$ (0.23)
Diluted net (loss) income per share	$ 0
Class A Ordinary shares
Other income (expense):
Net loss		$ (7,733,363)
Weighted Average Number of Shares Outstanding, Basic	0	33,743,836
Weighted Average Number of Shares Outstanding, Diluted	0	33,743,836
Basic net (loss) income per share	$ 0	$ (0.23)
Diluted net (loss) income per share	$ 0

STATEMENTS OF CHANGES IN SHAREH

STATEMENTS OF CHANGES IN SHAREHOLDERS (DEFICIT) EQUITY - USD ($)	Class A Ordinary sharesCommon Stock	Class A Ordinary shares	Class A Ordinary shares Subject to Redemption	Class B Ordinary sharesCommon Stock	Class B Ordinary shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Sep. 24, 2020	$ 0			$ 0		$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Sep. 24, 2020				0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B common stock to Sponsor				$ 863		24,137		25,000
Issuance of Class B common stock to Sponsor (in shares)				8,625,000
Net loss					$ (7,053)		(7,053)	(7,053)
Balance at the end at Dec. 31, 2020				$ 863		24,137	(7,053)	17,947
Balance at the end (in shares) at Dec. 31, 2020				8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		$ (7,733,363)			$ (1,971,014)		(9,704,377)	(9,704,377)
Accretion of redeemable Class A common stock to redemption amount			$ (45,277,970)			$ (24,137)	(45,253,833)	(45,277,970)
Balance at the end at Dec. 31, 2021				$ 863			$ (54,965,263)	$ (54,964,400)
Balance at the end (in shares) at Dec. 31, 2021				8,625,000

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net loss	$ (7,053)	$ (9,704,377)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation costs paid by related party	7,053	90,000
Interest earned on cash and investments held in trust	0	(150,792)
Loss on sale of private placement warrants	0	5,564,571
Change in fair value of warrant liabilities	0	(650,061)
Offering costs allocated to warrant liabilities	0	1,534,661
Changes in operating assets and liabilities:
Prepaid expenses and other non-current assets	0	(474,440)
Accounts payable and accrued expenses	0	2,162,642
Net cash used in operating activities	0	(1,627,796)
Cash Flows from Investing Activities:
Cash invested in Trust Account	0	(345,000,000)
Net cash used in investing activities	0	(345,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting commissions	0	338,100,000
Proceeds from issuance of Private Placement Warrants	0	9,400,000
Proceeds of promissory note - related party	0	14,898
Payment of promissory note - related party	0	(112,914)
Payment of offering costs	0	(635,718)
Net cash provided by financing activities	0	346,766,266
Net change in cash	0	138,470
Cash, beginning of period	0	0
Cash, end of the period	0	138,470
Supplemental disclosure of cash flow information
Deferred offering costs included in accrued expenses	320,829
Deferred offering costs paid by Sponsor in exchange for Class B ordinary shares	17,947
Deferred offering costs paid by Promissory Note - Related Party	98,016
Deferred underwriting commissions payable charged to additional paid-in capital	$ 0	$ 12,075,000

Organization and Business Opera

Organization and Business Operations	12 Months Ended
	Dec. 31, 2021
Organization and Business Operations
Organization and Business Operations	Note 1 — Organization and Business Operations Organization and General Poema Global Holdings Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on September 25, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“Business Combination”). As of December 31, 2021, the Company had not commenced any operations. All activity from September 25, 2020 (inception) through December 31, 2021 relates to the Company’s formation and the Initial Public Offering (the “IPO”) described below, and, since the closing of the IPO, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on the proceeds derived from the IPO and recognizes changes in the fair value of warrant liability as other income (expense). The registration statement for the Company’s IPO was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on January 5, 2021 (the “Effective Date”). On January 8, 2021, the Company consummated the IPO of 34,500,000 units (the “Units” and, with respect to the shares of Class A ordinary shares included in the Units sold, the “Public Shares”), including the issuance of 4,500,000 Units as a result of the underwriters’ full exercise of their over-allotment option. Each Unit consists of one share of Class A ordinary shares, $0.0001 par value, and one Simultaneously with the closing of the IPO, the Company consummated the private placement (“Private Placement”) with the Sponsor of an aggregate of 9,400,000 warrants (“Private Placement Warrants”) to purchase Class A ordinary shares, each at a price of $1.00 per Private Placement Warrant, generating total proceeds of $9,400,000 (Note 4). Transaction costs amounted to $19,746,681, consisting of $6,900,000 of underwriting commissions, $12,075,000 of deferred underwriting commissions and $771,681 of other offering costs. Following the closing of the IPO on January 8, 2021, an amount of $345,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement was placed in a trust account (“Trust Account”) which was be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940 (the “Investment Company Act”), with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, which invest only in direct U.S. government treasury obligations, until the earlier of (a) the completion of the Company’s initial Business Combination, (b) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s certificate of incorporation, or (c) the redemption of the Company’s public shares if the Company is unable to complete the initial Business Combination within 24 months from January 8, 2021 (the “Combination Period”), the closing of the IPO. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions) at the time of the Company’s signing a definitive agreement in connection with its initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target business or assets sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will only proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange rules and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange rules, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5), and any Public Shares purchased during or after the IPO in favor of approving a Business Combination. In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company has agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. Notwithstanding the above, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to shareholders’ rights (including redemption rights) or pre-initial business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the IPO, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern Consideration As of December 31, 2021, the Company had $138,470 in its operating bank account and working capital deficit of $1,646,143. The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, The Company repaid the Note in full on February 9, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but re not obligated to, provide the Company loans in order to finance transaction costs in connection with a Business Combination (“Working Capital Loans”). As of December 31, 2021 and 2020, there were no amounts outstanding under any Working Capital Loan. The Company may need to raise additional capital through loans or additional investments from its Sponsor, an affiliate of the Sponsor, or its officers or directors. The Company’s officers, directors and Sponsor, or their affiliates, may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, reducing overhead expenses, and extending the terms and due dates of certain accrued expenses and other liabilities. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. In connection with the Company’s assessment of going concern considerations in accordance with FASB accounting Standards Update (“ASU”) 2014- 15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the working capital deficit, as well as the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management plans to complete a business combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 8, 2023. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Significant Accounting Policies
Significant Accounting Policies	Note 2 — Significant Accounting Policies Basis of Presentation The accompanying financial statement is presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of these financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of these financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2021 and 2020. Cash and Investments Held in Trust Account At December 31, 2021, the cash held in Trust was $10,405 and the assets held in the Trust Account were held in U.S. Treasury Bills with a maturity of 185 days or less and in money market funds which invest U.S. Treasury securities. During the year ended December 31, 2021 and the period from September 25, 2020 (inception) through December 31, 2020, the Company did not withdraw any of the interest income from the Trust Account to pay its tax obligations. The Company classifies its United States Treasury securities as held-to-maturity in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 320 “ Investments - Debt and Equity Securities. A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry the investee operates in. Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion are included in the “interest income” line item in the statements of operations. Interest income is recognized when earned. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. As of December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Warrant Liabilities The Company evaluated the Public Warrants and Private Placement Warrants (collectively, “Warrants”, which are discussed in Note 3, Note 4, and Note 8) in accordance with ASC 815-40, “ Derivatives and Hedging — Contracts in Entity’s Own Equity Fair Value Measurement Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred, presented as non-operating expenses in the statements of operations. Offering costs associated with the Class A ordinary shares were charged to temporary equity upon the completion of the IPO. Class A ordinary shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “ Distinguishing Liabilities from Equity Income Taxes ASC Topic 740 prescribes a recognition threshold and measurement attributes for these financial statements recognition and measurements of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The deferred tax assets were deemed to be de minimis as of December 31, 2021 and 2020. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Loss Per Ordinary Share The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The 34,500,000 potential ordinary shares for outstanding warrants to purchase the Company’s shares were excluded from diluted earnings per share for the year ended December 31, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class of ordinary shares: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the year ended December 31, 2021 ​ Class A Class B Basic and diluted net loss per share: ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ Allocation of net loss ​ $ (7,733,363) ​ $ (1,971,014) Denominator: ​ ​ ​ ​ ​ ​ Weighted-average shares outstanding ​ ​ 33,743,836 ​ ​ 8,600,343 Basic and diluted net loss per share ​ $ (0.23) ​ $ (0.23) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the period from September ​ ​ 25, 2020 (inception) through ​ ​ December 31, 2020 ​ Class A Class B Basic and diluted net loss per share: ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ Allocation of net loss ​ $ — ​ $ (7,053) Denominator: ​ ​ ​ ​ ​ ​ Weighted-average shares outstanding ​ ​ — ​ ​ 7,500,000 Basic and diluted net loss per share ​ $ — ​ $ 0.00 ​ Fair Value of Financial Instruments The Company follows the guidance in ASC 820, “ Fair Value Measurement ,” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement See Note 8 for additional information on assets and liabilities measured at fair value. Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt --debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging -- Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity (“ASU 2020-06”) , which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. Management is currently evaluating the new guidance, but does not expect the adoption of this guidance to have a material impact on the Company’s financial statements. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements .

Initial Public Offering

Initial Public Offering	12 Months Ended
	Dec. 31, 2021
Initial Public Offering
Initial Public Offering	Note 3 — Initial Public Offering Public Units On January 8, 2021, the Company sold 34,500,000 Units at a price of $10.00 per Unit, including the issuance of 4,500,000 Units as a result of the underwriters’ full exercise of their over-allotment option. Each Unit consists of one one All of the 34,500,000 Class A ordinary shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s certificate of incorporation. In accordance with guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. The Class A ordinary shares is subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company recognizes changes in redemption value immediately as they occur. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable ordinary shares resulted in charges against additional paid-in capital and accumulated deficit. As of December 31, 2021, the ordinary shares reflected on the balance sheet are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds from IPO $ 345,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (27,085,950) Ordinary shares issuance costs ​ (18,192,020) Plus: ​ Accretion of carrying value to redemption value ​ 45,277,970 Class A ordinary shares subject to possible redemption ​ $ 345,000,000 ​ Public Warrants Each whole Public Warrant entitles the holder to purchase one share of the Company’s Class A ordinary shares at a price of $11.50 per share. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the IPO; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 : Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. If and when the warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00 : Once the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of our Class A ordinary shares; ● if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted) for any 20 trading days within the 30 -trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and ● redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Private Placement

Private Placement	12 Months Ended
	Dec. 31, 2021
Private Placement.
Private Placement.	Note 4 — Private Placement Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 9,400,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $9,400,000 in a private placement. A portion of the proceeds from the private placement was added to the proceeds from the IPO held in the Trust Account. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the IPO, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the Initial Shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Related Party Transactions
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares On September 30, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration of 7,187,500 shares of the Company’s Class B ordinary shares (the “Founder Shares”). On January 5, 2021, the Company effected a dividend of 0.2 of a share of Class B ordinary shares for each share of Class B ordinary shares, resulting in 8,625,000 shares of Class B ordinary shares being issued and outstanding no Promissory Note - Related Party The Sponsor had agreed to loan the Company an aggregate of up to $300,000 to be used for the payment of costs related to the IPO. The promissory note was non-interest bearing, unsecured and was due on the earlier of March 31, 2021 or the closing of the IPO. As of December 31, 2021 and 2020 the Company has borrowed $0 and $98,016, respectively, under the promissory note and is due on demand. The promissory note was paid in full on February 9, 2021. The facility is no longer available to the Company. Working Capital Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans, other than the interest on such proceeds that may be released for working capital purposes. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of December 31, 2021 and 2020, no Working Capital Loans were outstanding. Administrative Services Agreement The Company entered into an agreement, commencing January 5, 2021 through the earlier of the consummation of a business combination or our liquidation, to pay the Sponsor a monthly fee of $10,000 for office space, utilities, secretarial and administrative services. Upon completion of the initial Business Combination or liquidation, the Company will cease paying these monthly fees. The Company incurred $120,000 in expenses in connection with such services for the year ended December 31, 2021. As of December 31, 2021, $120,000 related to this agreement is recorded in accounts payable and accrued expenses on the Company’s balance sheets.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies
Commitments and Contingencies	Note 6 — Commitments and Contingencies Underwriting Agreement The underwriter had a 45-day option from the date of the IPO to purchase up to an aggregate of 4,500,000 additional Units at the public offering price less the underwriting commissions to cover over-allotments, if any. On January 8, 2021, the underwriters exercised the over-allotment in full, purchasing an additional 4,500,000 Units. On January 8, 2021, the underwriters were paid cash underwriting commissions of 2% of the gross proceeds of the IPO, totaling $6,900,000. In addition, $0.35 per unit, or approximately $12,075,000 in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Merger Agreement On September 16, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Gogoro Inc., an exempted company incorporated with limited liability under the laws of Cayman Islands (“Gogoro”), Starship Merger Sub I Limited, an exempted company incorporated with limited liability under the laws of Cayman Islands and a wholly-owned subsidiary of Gogoro (“Merger Sub”) and Starship Merger Sub II Limited, an exempted company incorporated with limited liability under the laws of Cayman Islands and a wholly-owned subsidiary of Gogoro (“Merger Sub II”), pursuant to which, among other transactions, on the terms and subject to the conditions set forth therein, (i) Merger Sub will merge with and into the Company (the “First Merger”), with the Company surviving the First Merger as a wholly owned subsidiary of Gogoro, and (ii) the Company will merge with and into Merger Sub II (the “Second Merger” and together with the First Merger, collectively, the “Mergers”), with Merger Sub II surviving the Second Merger as a wholly-owned subsidiary of Gogoro (the “Business Combination”). Refer to the Form 8-K filed on September 16, 2021 for additional details regarding the Merger Agreement.

Shareholders' (Deficit) Equity

Shareholders' (Deficit) Equity	12 Months Ended
	Dec. 31, 2021
Shareholders' (Deficit) Equity
Shareholders' (Deficit) Equity	Note 7 — Shareholders’ (Deficit) Equity Preference shares Class A ordinary shares issued outstanding Class B ordinary shares Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial business combination) at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the IPO, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of the Company’s management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2021
Fair Value Measurements
Fair Value Measurements	Note 8 — Fair Value Measurements The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Significant Other ​ Significant Other ​ ​ ​ ​ ​ Active Markets ​ Observable Inputs ​ Unobservable Inputs ​ December 31, 2021 (Level 1) (Level 2) (Level 3) Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account (1) ​ $ 345,140,387 ​ $ 345,140,387 ​ $ — ​ $ — ​ ​ $ 345,140,387 ​ $ 345,140,387 ​ $ — ​ $ — Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Public Warrants: Liabilities ​ $ 25,012,500 ​ $ 25,012,500 ​ $ — ​ $ — Private Placement Warrants: Liabilities ​ ​ 16,387,960 ​ ​ — ​ ​ — ​ ​ 16,387,960 ​ ​ $ 41,400,460 ​ $ 25,012,500 ​ $ — ​ $ 16,387,960 (1) This amount does not include the $10,405 of cash held in the trust account as of December 31, 2021 ​ The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the statements of operations. The Company established the initial fair value of the Public Warrants on January 8, 2021, the date of the Company’s IPO, using a Monte Carlo simulation model, and as of December 31, 2021 by using the associated trading price of the Public Warrants. The Company established the initial fair value of the Private Placement Warrants on January 8, 2021 and on December 31, 2021 by using a modified Black Scholes calculation. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. The Public Warrants were subsequently classified as Level 1 as the subsequent valuation was based upon the trading price of the Public Warrants. The key inputs into the Modified Black Scholes calculation as of January 8, 2021 (Initial Measurement) and December 31, 2021 were as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ January 8, 2021 ​ ​ ​ ​ ​ (Initial Measurement) December 31, 2021 ​ Inputs ​ ​ ​ ​ ​ ​ ​ Risk-free interest rate ​ ​ 0.65 % 1.28 % Expected term (years) to initial business combination ​ ​ 1.00 ​ 0.25 ​ Expected volatility ​ ​ 25.0 % ​ 20.8 % Notional Exercise price ​ $ 11.50 ​ $ 11.50 ​ ​ The change in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the year ended December 31, 2021 is summarized as follows: ​ ​ ​ ​ ​ ​ ​ Warrant ​ Liability Derivative warrant liabilities at January 1, 2021 ​ $ — Issuance of Public and Private Placement Warrants ​ 42,050,521 Change in fair value of warrant liabilities ​ ​ (16,175,061) Transfer of Public Warrants to Level 1 ​ (9,487,500) Derivative warrant liabilities at December 31, 2021 $ 16,387,960 ​

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2021
Subsequent Events
Subsequent Events	Note 9 — Subsequent Events On January 18, 2022, Hero MotoCorp, Engine No. 1 and another investor (the “Additional PIPE Investors”) entered into additional share subscription agreements (each, an “Additional PIPE Agreement”) pursuant to which the Additional PIPE Investors have committed to subscribe for and purchase 2,750,000 Gogoro Ordinary Share at $10.00 per share for an aggregate purchase price of $27,500,000 (the “Additional PIPE Financing”). Under the Additional PIPE Agreements, the obligations of the parties to consummate the Additional PIPE Financing are subject to the satisfaction or waiver of certain customary closing conditions including, among others, (i) the absence of a legal prohibition on consummating the Additional PIPE Financing, (ii) all conditions precedent under the Merger Agreement having been satisfied or waived, (iii) the accuracy of representations and warranties in all material respects and (iv) material compliance with covenants. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these financial statements. The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying financial statement is presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of these financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of these financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2021 and 2020.
Cash and Investments Held in Trust Account	Cash and Investments Held in Trust Account At December 31, 2021, the cash held in Trust was $10,405 and the assets held in the Trust Account were held in U.S. Treasury Bills with a maturity of 185 days or less and in money market funds which invest U.S. Treasury securities. During the year ended December 31, 2021 and the period from September 25, 2020 (inception) through December 31, 2020, the Company did not withdraw any of the interest income from the Trust Account to pay its tax obligations. The Company classifies its United States Treasury securities as held-to-maturity in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 320 “ Investments - Debt and Equity Securities. A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry the investee operates in. Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion are included in the “interest income” line item in the statements of operations. Interest income is recognized when earned.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. As of December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Warrant Liabilities	Warrant Liabilities The Company evaluated the Public Warrants and Private Placement Warrants (collectively, “Warrants”, which are discussed in Note 3, Note 4, and Note 8) in accordance with ASC 815-40, “ Derivatives and Hedging — Contracts in Entity’s Own Equity Fair Value Measurement
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred, presented as non-operating expenses in the statements of operations. Offering costs associated with the Class A ordinary shares were charged to temporary equity upon the completion of the IPO.
Class A ordinary shares Subject to Possible Redemption	Class A ordinary shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “ Distinguishing Liabilities from Equity
Income Taxes	Income Taxes ASC Topic 740 prescribes a recognition threshold and measurement attributes for these financial statements recognition and measurements of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The deferred tax assets were deemed to be de minimis as of December 31, 2021 and 2020. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The 34,500,000 potential ordinary shares for outstanding warrants to purchase the Company’s shares were excluded from diluted earnings per share for the year ended December 31, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class of ordinary shares: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the year ended December 31, 2021 ​ Class A Class B Basic and diluted net loss per share: ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ Allocation of net loss ​ $ (7,733,363) ​ $ (1,971,014) Denominator: ​ ​ ​ ​ ​ ​ Weighted-average shares outstanding ​ ​ 33,743,836 ​ ​ 8,600,343 Basic and diluted net loss per share ​ $ (0.23) ​ $ (0.23) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the period from September ​ ​ 25, 2020 (inception) through ​ ​ December 31, 2020 ​ Class A Class B Basic and diluted net loss per share: ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ Allocation of net loss ​ $ — ​ $ (7,053) Denominator: ​ ​ ​ ​ ​ ​ Weighted-average shares outstanding ​ ​ — ​ ​ 7,500,000 Basic and diluted net loss per share ​ $ — ​ $ 0.00
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company follows the guidance in ASC 820, “ Fair Value Measurement ,” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement See Note 8 for additional information on assets and liabilities measured at fair value.
Recent Accounting Standards	Recent Accounting Standards In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt --debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging -- Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity (“ASU 2020-06”) , which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. Management is currently evaluating the new guidance, but does not expect the adoption of this guidance to have a material impact on the Company’s financial statements. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements .

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Significant Accounting Policies
Schedule of reconciliation of net loss per common share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the year ended December 31, 2021 ​ Class A Class B Basic and diluted net loss per share: ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ Allocation of net loss ​ $ (7,733,363) ​ $ (1,971,014) Denominator: ​ ​ ​ ​ ​ ​ Weighted-average shares outstanding ​ ​ 33,743,836 ​ ​ 8,600,343 Basic and diluted net loss per share ​ $ (0.23) ​ $ (0.23) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the period from September ​ ​ 25, 2020 (inception) through ​ ​ December 31, 2020 ​ Class A Class B Basic and diluted net loss per share: ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ Allocation of net loss ​ $ — ​ $ (7,053) Denominator: ​ ​ ​ ​ ​ ​ Weighted-average shares outstanding ​ ​ — ​ ​ 7,500,000 Basic and diluted net loss per share ​ $ — ​ $ 0.00

Initial Public Offering (Tables

Initial Public Offering (Tables)	12 Months Ended
	Dec. 31, 2021
Initial Public Offering
Summary of reconciliation of ordinary shares reflected on balance sheet	​ ​ ​ ​ ​ Gross proceeds from IPO $ 345,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (27,085,950) Ordinary shares issuance costs ​ (18,192,020) Plus: ​ Accretion of carrying value to redemption value ​ 45,277,970 Class A ordinary shares subject to possible redemption ​ $ 345,000,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Measurements
Schedule of Company's assets and financial liabilities that are measured at fair value on a recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Prices in Significant Other ​ Significant Other ​ ​ ​ ​ ​ Active Markets ​ Observable Inputs ​ Unobservable Inputs ​ December 31, 2021 (Level 1) (Level 2) (Level 3) Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account (1) ​ $ 345,140,387 ​ $ 345,140,387 ​ $ — ​ $ — ​ ​ $ 345,140,387 ​ $ 345,140,387 ​ $ — ​ $ — Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Public Warrants: Liabilities ​ $ 25,012,500 ​ $ 25,012,500 ​ $ — ​ $ — Private Placement Warrants: Liabilities ​ ​ 16,387,960 ​ ​ — ​ ​ — ​ ​ 16,387,960 ​ ​ $ 41,400,460 ​ $ 25,012,500 ​ $ — ​ $ 16,387,960 (1) This amount does not include the $10,405 of cash held in the trust account as of December 31, 2021
Schedule of quantitative information regarding Level 3 fair value measurements inputs	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ January 8, 2021 ​ ​ ​ ​ ​ (Initial Measurement) December 31, 2021 ​ Inputs ​ ​ ​ ​ ​ ​ ​ Risk-free interest rate ​ ​ 0.65 % 1.28 % Expected term (years) to initial business combination ​ ​ 1.00 ​ 0.25 ​ Expected volatility ​ ​ 25.0 % ​ 20.8 % Notional Exercise price ​ $ 11.50 ​ $ 11.50 ​
Schedule of change in the fair value of derivative warrant liabilities	​ ​ ​ ​ ​ ​ ​ Warrant ​ Liability Derivative warrant liabilities at January 1, 2021 ​ $ — Issuance of Public and Private Placement Warrants ​ 42,050,521 Change in fair value of warrant liabilities ​ ​ (16,175,061) Transfer of Public Warrants to Level 1 ​ (9,487,500) Derivative warrant liabilities at December 31, 2021 $ 16,387,960

Organization and Business Ope_2

Organization and Business Operations (Details) - USD ($)	Jan. 08, 2021	Dec. 31, 2021	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Price per share		$ 10
Threshold Minimum Aggregate Fair Market Value As Percentage Of Assets Held In Trust Account		80.00%
Threshold Percentage Of Outstanding Voting Securities Of Target To Be Acquired By Post Transaction Company To Complete Business Combination		50.00%
Minimum net tangible assets required to process with a Business Combination		$ 5,000,001
Threshold percentage of public shares subject to redemption without Company's prior written consent		15.00%
Transaction Costs		$ 19,746,681
Underwriting fees		6,900,000
Deferred underwriting commission		12,075,000
Other offering costs		771,681
Cash held outside the Trust Account		138,470	$ 0
Working capital deficit		$ 1,646,143
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)		100.00%
Contribution from sponsor to cover certain expenses		$ 25,000
Class A Ordinary shares Subject to Redemption
Subsidiary, Sale of Stock [Line Items]
Gross proceeds from sale of units		345,000,000
IPO
Subsidiary, Sale of Stock [Line Items]
Number of new units issued during the period.	34,500,000
Price per share	$ 10
Gross proceeds from sale of units	$ 345,000,000
Deferred underwriting commission	$ 12,075,000
IPO | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Price per share	$ 11.50
Common shares, par value, (per share)	$ 0.0001
Number of shares in a unit	1
Number of warrants in a unit	0.5
Number of shares per warrant	1
Private Placement | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	9,400,000
Proceeds from issuance , gross	$ 9,400,000
Price of warrant	$ 1
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of new units issued during the period.	4,500,000
Working Capital Loan
Subsidiary, Sale of Stock [Line Items]
Loan outstanding		$ 0	$ 0

Significant Accounting Polici_4

Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash and investments held in Trust Account	$ 345,150,792	$ 0
Federal Depository Insurance Coverage	$ 250,000
Anti-dilutive securities attributable to warrants (in shares)	34,500,000
Class A Ordinary shares
Temporary equity, shares outstanding	34,500,000	0
U.S. Treasury Securities
Cash and investments held in Trust Account	$ 10,405

Significant Accounting Polici_5

Significant Accounting Policies - Reconciliation of Net Income (Loss) per Common Share (Details) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Net (loss) income	$ (7,053)	$ (9,704,377)
Class A Ordinary shares
Net (loss) income		$ (7,733,363)
Weighted Average Number of Shares Outstanding, Basic	0	33,743,836
Weighted Average Number of Shares Outstanding, Diluted	0	33,743,836
Basic net (loss) income per share	$ 0	$ (0.23)
Diluted net (loss) income per share	$ 0
Class B Ordinary shares
Net (loss) income	$ (7,053)	$ (1,971,014)
Weighted Average Number of Shares Outstanding, Basic	7,500,000	8,600,343
Weighted Average Number of Shares Outstanding, Diluted	7,500,000	8,600,343
Basic net (loss) income per share	$ 0	$ (0.23)
Diluted net (loss) income per share	$ 0

Initial Public Offering (Detail

Initial Public Offering (Details)	Jan. 08, 2021$ / sharesshares	Dec. 31, 2021D$ / shares	Dec. 31, 2020$ / shares
Subsidiary, Sale of Stock [Line Items]
Issue price per share		$ 10
Class A Ordinary shares
Subsidiary, Sale of Stock [Line Items]
Common shares, par value, (per share)		0.0001	$ 0.0001
Public Warrants
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrants		$ 11.50
Public Warrant exercisable term after the completion of a business combination		30 days
Public Warrants exercisable term from the closing of the initial public offering		12 months
Threshold period for filling registration statement after business combination		20 days
Maximum threshold period for registration statement to become effective after business combination		60 days
Public Warrants expiration term		5 years
Fair market value per share		$ 0.361
Number of trading days on which fair market value of shares is reported | D		10
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00
Subsidiary, Sale of Stock [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)		$ 10
Redemption price per public warrant (in dollars per share)		$ 0.10
Adjustment of redemption price of warrants based on market value and newly issued price (as a percent)		180.00%
Redemption period		30 days
Threshold consecutive trading days for redemption of public warrants | D		20
Threshold Number of Business Days Before Sending Notice of Redemption to Warrant Holders		30 days
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Subsidiary, Sale of Stock [Line Items]
Minimum threshold written notice period for redemption of public warrants		30 days
Stock price trigger for redemption of public warrants (in dollars per share)		$ 18
Redemption price per public warrant (in dollars per share)		$ 0.01
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)		115.00%
Redemption period		30 days
Threshold trading days for redemption of public warrants | D		20
Public Warrants | Class A Ordinary shares
Subsidiary, Sale of Stock [Line Items]
Issue price per share		$ 9.20
Percentage of gross proceeds on total equity proceeds		60.00%
Threshold consecutive trading days for redemption of public warrants | D		20
IPO
Subsidiary, Sale of Stock [Line Items]
Number of new units issued during the period. | shares	34,500,000
Issue price per share	$ 10
IPO | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Common shares, par value, (per share)	0.0001
Issue price per share	$ 11.50
Number of shares in a unit | shares	1
Number of warrants in a unit | shares	0.5
Number of shares issuable per warrant | shares	1
Exercise price of warrants	$ 11.50
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of new units issued during the period. | shares	4,500,000

Initial Public Offering - Summa

Initial Public Offering - Summary of reconciliation of ordinary shares reflected on balance sheet (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Accretion of carrying value to redemption value	$ 45,277,970
Class A Ordinary shares Subject to Redemption
Gross proceeds from IPO	345,000,000
Proceeds allocated to Public Warrants	(27,085,950)
Ordinary shares issuance costs	(18,192,020)
Accretion of carrying value to redemption value	45,277,970
Ordinary shares subject to possible redemption	$ 345,000,000	$ 0

Private Placement (Details)

Private Placement (Details) - USD ($)	Jan. 08, 2021	Dec. 31, 2020	Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Aggregate purchase price		$ 0	$ 9,400,000
Private Placement | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued	9,400,000
Price of warrants	$ 1
Aggregate purchase price	$ 9,400,000

Related Party Transactions - Fo

Related Party Transactions - Founder Shares (Details) - USD ($)	Jan. 05, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2021	Jan. 08, 2021
Related Party Transaction [Line Items]
Aggregate purchase price			$ 25,000
Class B Ordinary shares
Related Party Transaction [Line Items]
Common shares, shares issued (in shares)			8,625,000	8,625,000
Common shares, shares outstanding (in shares)			8,625,000	8,625,000
Founder Shares
Related Party Transaction [Line Items]
Common shares, shares outstanding (in shares)				8,625,000
Founder Shares | Over-allotment option
Related Party Transaction [Line Items]
Shares subject to forfeiture					0
Founder Shares | Class B Ordinary shares
Related Party Transaction [Line Items]
Share dividend	0.2
Common shares, shares issued (in shares)	8,625,000
Common shares, shares outstanding (in shares)	8,625,000
Shares subject to forfeiture	1,125,000
Founder Shares | Class B Ordinary shares | IPO
Related Party Transaction [Line Items]
Shares subject to forfeiture					1,125,000
Founder Shares | Sponsor | Class B Ordinary shares
Related Party Transaction [Line Items]
Aggregate purchase price		$ 25,000
Number of shares issued		7,187,500

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	Jan. 05, 2021	Dec. 31, 2020	Dec. 31, 2021	Jan. 08, 2021
Related Party Transaction [Line Items]
Promissory note borrowed		$ 98,016	$ 0
Repayment of promissory note - related party		0	112,914
Working Capital Loans outstanding		0	0
Promissory Note with Related Party
Related Party Transaction [Line Items]
Promissory note borrowed		$ 98,016	0
Administrative Support Agreement
Related Party Transaction [Line Items]
Administrative service incurred amount			120,000
Due to related party			120,000
Sponsor
Related Party Transaction [Line Items]
Loan conversion agreement warrant			$ 1,500,000
Administrative Fees Expense	$ 10,000
Sponsor | Working capital loans warrant
Related Party Transaction [Line Items]
Price of warrant			$ 1
Sponsor | Promissory Note with Related Party | IPO
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note				$ 300,000

Commitments and Contingencies (

Commitments and Contingencies (Details)	Jan. 08, 2021USD ($)$ / sharesshares	Dec. 31, 2021USD ($)
Deferred underwriting commissions		$ 12,075,000
Over-allotment option
Granted Term	45 days
Number of new units issued during the period. | shares	4,500,000
Underwriting commission ( as a percent)	0.02
IPO
Number of new units issued during the period. | shares	34,500,000
Underwriting commission paid	$ 6,900,000
Deferred fee per unit | $ / shares	$ 0.35
Deferred underwriting commissions	$ 12,075,000

Shareholders' (Deficit) Equity

Shareholders' (Deficit) Equity - Common Stock Shares (Details)	12 Months Ended
	Dec. 31, 2021Vote$ / sharesshares	Dec. 31, 2020$ / sharesshares
Class of Stock [Line Items]
Common shares, votes per share | Vote	1
Class A Ordinary shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	500,000,000	500,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Common shares, shares issued (in shares)	0	0
Common shares, shares outstanding (in shares)	0	0
Temporary equity, shares outstanding	34,500,000	0
Temporary equity, shares issued	34,500,000	0
Class A Ordinary shares Subject to Redemption
Class of Stock [Line Items]
Temporary equity, shares outstanding	34,500,000	0
Class B Ordinary shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	50,000,000	50,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Common shares, shares issued (in shares)	8,625,000	8,625,000
Common shares, shares outstanding (in shares)	8,625,000	8,625,000
Ratio to be applied to the stock in the conversion	20

Shareholders' (Deficit) Equity-

Shareholders' (Deficit) Equity- Preferred Stock Shares (Details) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Shareholders' (Deficit) Equity
Preferred shares, shares authorized	5,000,000	5,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Assets:
Cash and investments held in Trust Account	$ 345,150,792	$ 0
Liabilities:
Warrant liabilities	41,400,460	$ 0
Recurring
Assets:
Cash and investments held in Trust Account	345,140,387
Total	345,140,387
Liabilities:
Total	41,400,460
Recurring | Public Warrants
Liabilities:
Warrant liabilities	25,012,500
Recurring | Private Placement Warrants
Liabilities:
Warrant liabilities	16,387,960
U.S. Treasury Securities
Assets:
Cash and investments held in Trust Account	10,405
U.S. Treasury Securities | Recurring
Assets:
Cash and investments held in Trust Account	10,405
Level 1 | Recurring
Assets:
Cash and investments held in Trust Account	345,140,387
Total	345,140,387
Liabilities:
Total	25,012,500
Level 1 | Recurring | Public Warrants
Liabilities:
Warrant liabilities	25,012,500
Level 3 | Recurring
Liabilities:
Total	16,387,960
Level 3 | Recurring | Private Placement Warrants
Liabilities:
Warrant liabilities	$ 16,387,960

Fair Value Measurements - Measu

Fair Value Measurements - Measurements Inputs (Details)	Dec. 31, 2021$ / shares	Jan. 08, 2021$ / shares
Risk-free interest rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement Input	1.28	0.65
Expected term (years) to initial business combination
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement Input	0.25	1
Expected volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement Input	20.8	25
Notional Exercise price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement Input	11.50	11.50

Fair Value Measurements - Chang

Fair Value Measurements - Change in fair value, Level 3 Inputs (Details)	12 Months Ended
	Dec. 31, 2021USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Derivative warrant liabilities, beginning	$ 0
Issuance of Public and Private Placement Warrants	42,050,521
Basic and diluted net loss per share, Class A ordinary shares	(16,175,061)
Transfer of Public Warrants to Level 1	(9,487,500)
Change in fair value of derivative warrant liabilities	(16,175,061)
Derivative warrant liabilities, ending	$ 16,387,960

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Jan. 18, 2022	Dec. 31, 2020	Dec. 31, 2021
Subsequent Event [Line Items]
Price per share			$ 10
Aggregate purchase price		$ 25,000
Additional PIPE Agreement | Subsequent events
Subsequent Event [Line Items]
Number of shares issued	2,750,000
Price per share	$ 10
Aggregate purchase price	$ 27,500,000